Talk:WikiJournal of Medicine/Acute gastrointestinal bleeding from a chronic cause: a teaching case report

Plagiarism check
Pass. Report from Small Seo Tools software: 0% Plagiarism, 100% Unique. Mikael Häggström (discuss • contribs) 17:11, 30 November 2016 (UTC)

Comment on reply
Thanks for your reply. I am not sure how to handle the wiki-syntax so here you are my reply. I am glad about the current version and satisfied about all changes except one point that need further discussion. All doctors are busy. I suggest that the editors should send reminding alerts on frequant basis.
 * I think that what is used in GI bleeding is Octeriotide which is a somatostatin analog. I am aware of just one company producing it as Sandostatin. It is labled as a "Somatostatin analog", check this website linksandostatin. I assumed that your hospital used this medication. We can not refer to any analog by the original name of the hormone whatever was their resemblance. For example Hydrocortisone and Dexamethasone can be considered as analogs of Cortisol. Although they share high chemical resemblance features, but the three compounds are not he same chemically and differ clinically in their pharmacologic effect, e.g. half life, antiinflammatory strength, mineralcorticoid effect, glucocorticoid effect among other differences. I would appreciate to update me if you have the original Somatostatin hormone available in your hospital and sharing how you prescribe it. May be Octeriotide is famous as Somatostatin in some medical circles but it is a Somatostatin analog. Also, after searching on web seems there are other Somatostatin analogs as Octereotate Octreotate, pasireotide, lanreotideList of Somatostatin and somatostatin analogs. I think Somatostatin would have a short T1/2 as all natural hormones. Most probably a somatostatin analog was used. Please update me. Otherwise the article is mature and is ready for publishing as an addition to medical knowledge.--Ashashyou (discuss • contribs) 19:38, 9 April 2017 (UTC)


 * Thanks for clarification. I am indebted for updating my knowledge. As i mentioned before "the article is mature and is ready for publishing as an addition to medical knowledge". It would be nice if you could give a hint about the somatostatin used in this case, as i think most readers would assume it to be somatostatin analogue, if possible. Good luck--Ashashyou (discuss • contribs) 20:25, 2 August 2017 (UTC)

Minor edit for reference consistency
Hello! With this edit, I found and added DOIs to the remaining reference articles that did not have them listed. I also tried to make the ISO 4 journal abbreviations consistent across citations. If you disagree with any elements of the edit, please feel free to change them back to the way they were. Thanks! Bobamnertiopsis (discuss • contribs) 19:44, 15 June 2017 (UTC)


 * Hello! Thank you for adding missing DOIs and providing consistency. We welcome your helpful contributions, please feel free to continue. Thanks! Ear-phone (discuss • contribs) 09:37, 22 June 2017 (UTC)

External peer review 2
Following are comments from a physician and professor in clinical hepatology, who wants to remain anonymous. We can regard the peer review to have no conflicts of interest. Mikael Häggström (discuss • contribs) 20:01, 13 July 2017 (UTC)